Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.

Pittman AM, Myers AJ, Abou-Sleiman P, Fung HC, Kaleem M, Marlowe L, Duckworth J, Leung D, Williams D, Kilford L, Thomas N, Morris CM, Dickson D, Wood NW, Hardy J, Lees AJ, de Silva R.

J Med Genet. 2005 Nov;42(11):837-46. Epub 2005 Mar 25.

2.

Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Caffrey TM, Wade-Martins R.

Neurobiol Dis. 2007 Jul;27(1):1-10. Epub 2007 May 5. Review.

3.

Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease.

Borroni B, Agosti C, Magnani E, Di Luca M, Padovani A.

Curr Med Chem. 2011;18(17):2655-60. Review.

PMID:
21568901
4.

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Zhang CC, Zhu JX, Wan Y, Tan L, Wang HF, Yu JT, Tan L.

Oncotarget. 2017 Jul 4;8(27):44994-45007. doi: 10.18632/oncotarget.16690. Review.

5.

Untangling the tau gene association with neurodegenerative disorders.

Pittman AM, Fung HC, de Silva R.

Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R188-95. Review.

PMID:
16987883
6.

Disentangling the role of the tau gene locus in sporadic tauopathies.

Vandrovcova J, Anaya F, Kay V, Lees A, Hardy J, de Silva R.

Curr Alzheimer Res. 2010 Dec;7(8):726-34. Review.

PMID:
20704554
7.

From 1997 to 2007: a decade journey through the H1 haplotype on 17q21 chromosome.

Kalinderi K, Fidani L, Bostantjopoulou S.

Parkinsonism Relat Disord. 2009 Jan;15(1):2-5. doi: 10.1016/j.parkreldis.2008.03.001. Epub 2008 Apr 18. Review.

PMID:
18424220
8.

Progressive supranuclear palsy--parkinsonian disorder with tau pathology.

Kowalska A, Jamrozik Z, Kwieciński H.

Folia Neuropathol. 2004;42(2):119-23. Review.

PMID:
15266787
9.

Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?

Sha S, Hou C, Viskontas IV, Miller BL.

Nat Clin Pract Neurol. 2006 Dec;2(12):658-65. Review.

PMID:
17117169
10.

Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Dickson DW, Kouri N, Murray ME, Josephs KA.

J Mol Neurosci. 2011 Nov;45(3):384-9. doi: 10.1007/s12031-011-9589-0. Epub 2011 Jul 1. Review.

11.

Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.

Yoshida M.

Neuropathology. 2014 Dec;34(6):555-70. doi: 10.1111/neup.12143. Epub 2014 Aug 14. Review.

PMID:
25124031
12.

Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.

Kertesz A, Munoz D.

Dement Geriatr Cogn Disord. 2004;17(4):282-6. Review.

PMID:
15178937
13.

Unraveling progressive supranuclear palsy: from the bedside back to the bench.

Houghton DJ, Litvan I.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S341-6. doi: 10.1016/S1353-8020(08)70028-2. Review.

PMID:
18267262
14.

Clinical and genetic aspects of progressive supranuclear palsy.

Litvan I, Hutton M.

J Geriatr Psychiatry Neurol. 1998 Summer;11(2):107-14. Review.

PMID:
9877531
15.

Evidence suggesting that Homo neanderthalensis contributed the H2 MAPT haplotype to Homo sapiens.

Hardy J, Pittman A, Myers A, Gwinn-Hardy K, Fung HC, de Silva R, Hutton M, Duckworth J.

Biochem Soc Trans. 2005 Aug;33(Pt 4):582-5. Review.

PMID:
16042549
16.

The molecular genetics of the tauopathies.

van Slegtenhorst M, Lewis J, Hutton M.

Exp Gerontol. 2000 Jul;35(4):461-71. Review.

PMID:
10959034
17.

MAPT-Related Disorders.

van Swieten JC, Rosso SM, Heutink P.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2000 Nov 7 [updated 2010 Oct 26].

Supplemental Content

Support Center